For example, Oncaspar®, a pegylated form of the enzyme asparaginase (PEG-ASNase), was approved by the FDA in 1994 for pediatric Acute Lymphoblastic Leukemia (ALL) [118]. Here, ASPG is linked to acute lymphoblastic leukemia.